SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-022601
Filing Date
2018-04-05
Accepted
2018-04-05 10:05:18
Documents
1
Period of Report
2018-03-12

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3864
  Complete submission text file 0001104659-18-022601.txt   5244
Mailing Address C/O CYTORI THERAPEUTICS, INC. 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 858-458-0900
Saad Mark E (Reporting) CIK: 0001295913 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37635 | Film No.: 18739533

Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations